Charles River Laboratories International Minority Interest

As of the most recent data (June 2026), CRL shows a minority interest of $6.4M. That compares with $46M in the prior-year period — down 86.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRL's minority interest is now $6.4M (was $46M) — a 86.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Charles River Laboratories International is outperforming or lagging.

Tracking CRL's minority interest over time shows whether Charles River Laboratories International is scaling, shrinking, or reshaping that part of the business. The current reading is $6.4M That compares with $46M in the prior-year period — down 86.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Charles River Laboratories International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $6.4M) with ownership activity and broader fundamentals.

Charles River Laboratories International's minority interest is $6.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.